In vivo neutralization of coral snake venoms with an oligoclonal nanobody mixture in a murine challenge model


Nature Communications


Benard-Valle, M., Wouters, Y., Ljungars, A., Thi Tuyet Nguyen, G., Ahmadi, S., Wainani Ebersole, T., Holst Dahl, C., Guadarrama-Martínez, A., Jeppesen, F., Eriksen, H., Rodríguez-Barrera, G., Boddum, K., Patrick Jenkins, T., Petersen Bjørn, S., Schoffelen, S., Gunnar Voldborg, B., Alagón, A., & Hougaard Laustsen, A.



Oligoclonal mixtures of broadly-neutralizing antibodies can neutralize complex compositions of similar and dissimilar antigens, making them versatile tools for the treatment of e.g., infectious diseases and animal envenomations. However, these biotherapeutics are complicated to develop due to their complex nature. In this work, we describe the application of various strategies for the discovery of cross-neutralizing nanobodies against key toxins in coral snake venoms using phage display technology. We prepare two oligoclonal mixtures of nanobodies and demonstrate their ability to neutralize the lethality induced by two North American coral snake venoms in mice, while individual nanobodies fail to do so. We thus show that an oligoclonal mixture of nanobodies can neutralize the lethality of venoms where the clinical syndrome is caused by more than one toxin family in a murine challenge model. The approaches described may find utility for the development of advanced biotherapeutics against snakebite envenomation and other pathologies where multi-epitope targeting is beneficial.

Keywords: Q2 2024

Go to journal

Get in Touch

We strive to provide the best for our customers, and we are always ready to help. Please let us know if you have a question for us.

Follow us